Barclays’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-75,900
Closed -$19M 5266
2025
Q4
$19M Buy
+75,900
New +$20.2M ﹤0.01% 1273
2022
Q1
Sell
-96,146
Closed -$26M 5325
2021
Q4
$26M Buy
+96,146
New +$23.8M 0.01% 841
2020
Q2
Sell
-9,079
Closed -$986K 5950
2020
Q1
$986K Buy
+9,079
New +$1.31M ﹤0.01% 2970
2019
Q4
Sell
-466
Closed -$67K 6602
2019
Q3
$67K Sell
466
-15,132
-97% -$2.21M ﹤0.01% 5753
2019
Q2
$2.32M Sell
15,598
-20,835
-57% -$2.91M ﹤0.01% 2730
2019
Q1
$4.79M Buy
36,433
+32,243
+770% +$3.97M ﹤0.01% 1693
2018
Q4
$455K Buy
4,190
+2,444
+140% +$327K ﹤0.01% 3893
2018
Q3
$261K Sell
1,746
-3,259
-65% -$496K ﹤0.01% 4789
2018
Q2
$772K Sell
5,005
-4,423
-47% -$668K ﹤0.01% 3543
2018
Q1
$1.31M Buy
9,428
+6,518
+224% +$957K ﹤0.01% 2902
2017
Q4
$399K Buy
2,910
+233
+9% +$30.8K ﹤0.01% 4081
2017
Q3
$347K Sell
2,677
-37,714
-93% -$5.03M ﹤0.01% 3951
2017
Q2
$5.35M Buy
40,391
+2,095
+5% +$257K 0.01% 1417
2017
Q1
$4.72M Buy
38,296
+32,243
+533% +$3.82M 0.01% 1367
2016
Q4
$668K Buy
6,053
+2,095
+53% +$233K ﹤0.01% 3117
2016
Q3
$467K Buy
3,958
+2,910
+278% +$343K ﹤0.01% 3294
2016
Q2
$117K Sell
1,048
-67,162
-98% -$7.23M ﹤0.01% 4297
2016
Q1
$6.86M Buy
68,210
+67,861
+19,444% +$6.51M 0.01% 969
2015
Q4
$37K Sell
349
-815
-70% -$84.1K ﹤0.01% 4958
2015
Q3
$108K Sell
1,164
-6,868
-86% -$710K ﹤0.01% 4578
2015
Q2
$835K Buy
8,032
+7,916
+6,824% +$824K ﹤0.01% 3045
2015
Q1
$13K Sell
116
-3,609
-97% -$371K ﹤0.01% 6075
2014
Q4
$342K Sell
3,725
-7,799
-68% -$689K ﹤0.01% 4199
2014
Q3
$1M Buy
11,524
+4,656
+68% +$421K ﹤0.01% 3352
2014
Q2
$601K Sell
6,868
-60,178
-90% -$5.21M ﹤0.01% 3798
2014
Q1
$5.64M Buy
67,046
+7,915
+13% +$631K 0.01% 1606
2013
Q4
$4.62M Buy
59,131
+36,433
+161% +$3.11M ﹤0.01% 1892
2013
Q3
$1.93M Buy
22,698
+10,127
+81% +$853K ﹤0.01% 2624
2013
Q2
$1.08M Buy
+12,571
New +$1.04M ﹤0.01% 3255

Other funds holding LH

Barclays's LH Position: Q1 2026 in Review

Barclays reduced its Labcorp (LH) stake by 29% in Q1 2026, selling an estimated $15.6M and leaving 143,744 shares worth $38.4M. The position accounts for 0.01% of the portfolio, ranked #823.

Barclays first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $139M in Q3 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Barclays held 143,744 shares of Labcorp worth $38.4M as of Q1 2026.
  • Barclays sold 57,599 Labcorp shares in Q1 2026, an estimated $15.6M.
  • Labcorp made up 0.01% of Barclays's portfolio in Q1 2026, its #823 holding.
  • Barclays first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Labcorp position peaked at $139M in Q3 2024.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.